Importer of Controlled Substances Application: Globyz Pharma, LLC, 49550 [2019-20417]

Download as PDF 49550 Federal Register / Vol. 84, No. 183 / Friday, September 20, 2019 / Notices Dated: September 11, 2019. Julie H. Ernstein, Supervisory Archeologist, National Register of Historic Places/National Historic Landmarks Program. Dated: August 20, 2019. Neil D. Doherty, Acting Assistant Administrator. Dated: August 20, 2019. Neil D. Doherty, Acting, Assistant Administrator. [FR Doc. 2019–20417 Filed 9–19–19; 8:45 am] [FR Doc. 2019–20413 Filed 9–19–19; 8:45 am] BILLING CODE 4410–09–P BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE DEPARTMENT OF JUSTICE Drug Enforcement Administration Drug Enforcement Administration [FR Doc. 2019–20375 Filed 9–19–19; 8:45 am] BILLING CODE 4312–52–P DEPARTMENT OF JUSTICE [Docket No. DEA–392] [Docket No. DEA–392] Drug Enforcement Administration Importer of Controlled Substances Application: Fisher Clinical Services, Inc. [Docket No. DEA–392] Importer of Controlled Substances Application: Globyz Pharma, LLC ACTION: ACTION: Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before October 21, 2019. Such persons may also file a written request for a hearing on the application on or before October 21, 2019. DATES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. ADDRESSES: In accordance with 21 CFR 1301.34(a), this is notice that on June 4, 2019, Globyz Pharma, LLC, 2101 Market Street, Suite 5, Boothwyn, Pennsylvania 19061–4001 applied to be registered as an importer of the following basic classes of controlled substance: khammond on DSKJM1Z7X2PROD with NOTICES SUPPLEMENTARY INFORMATION: Controlled substance Drug code Schedule Oxycodone ............... 9143 II The company plans to import the listed controlled substance to complete analytical testing. VerDate Sep<11>2014 17:13 Sep 19, 2019 Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before October 21, 2019. Such persons may also file a written request for a hearing on the application on or before October 21, 2019. Jkt 247001 Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. ADDRESSES: In accordance with 21 CFR 1301.34(a), this is notice that on July 19, 2019, Fisher Clinical Services, Inc., 7554 Schantz Road, Allentown, Pennsylvania 18106 applied to be registered as an importer of the following basic classes of controlled substances: SUPPLEMENTARY INFORMATION: Controlled substance Psilocybin ................. Methylphenidate ....... Levorphanol .............. Noroxymorphone ...... Tapentadol ................ Drug code 7437 1724 9220 9668 9780 Schedule I II II II II The company plans to import the listed controlled substances for clinical trials only. PO 00000 Frm 00045 Fmt 4703 Sfmt 4703 ACTION: Notice of registration. The registrants listed below have applied for and been granted registration by the Drug Enforcement Administration (DEA) as importers of schedule I and II controlled substances. SUPPLEMENTARY INFORMATION: The companies listed below applied to be registered as an importers of various basic classes of schedule I and II controlled substances. Information on previously published notices is listed in the table below. No comments or objections were submitted and no requests for a hearing were submitted for these notices. SUMMARY: Notice of application. DATES: Notice of application. Importer of Controlled Substances Registration Companies FR Docket Published Sigma Aldrich Co., LLC. 84 FR 31620 July 2, 2019. The DEA has considered the factors in 21 U.S.C. 823, 952(a) and 958(a) and determined that the registration of the listed registrants to import the applicable various basic classes of schedule I and II controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated each of the company’s maintenance of effective controls against diversion by inspecting and testing each company’s physical security systems, verifying each company’s compliance with state and local laws, and reviewing each company’s background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the DEA has granted a registration as an importer for schedule I and II controlled substances to the above listed companies. Dated: August 23, 2019. Neil D. Doherty, Acting Assistant Administrator. [FR Doc. 2019–20416 Filed 9–19–19; 8:45 am] BILLING CODE 4410–09–P E:\FR\FM\20SEN1.SGM 20SEN1

Agencies

[Federal Register Volume 84, Number 183 (Friday, September 20, 2019)]
[Notices]
[Page 49550]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-20417]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Importer of Controlled Substances Application: Globyz Pharma, LLC

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic classes, and 
applicants therefore, may file written comments on or objections to the 
issuance of the proposed registration on or before October 21, 2019. 
Such persons may also file a written request for a hearing on the 
application on or before October 21, 2019.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a 
hearing must be sent to: Drug Enforcement Administration, Attn: 
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All 
requests for a hearing should also be sent to: (1) Drug Enforcement 
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, 
Springfield, Virginia 22152; and (2) Drug Enforcement Administration, 
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, 
Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this 
is notice that on June 4, 2019, Globyz Pharma, LLC, 2101 Market Street, 
Suite 5, Boothwyn, Pennsylvania 19061-4001 applied to be registered as 
an importer of the following basic classes of controlled substance:

------------------------------------------------------------------------
         Controlled substance           Drug code         Schedule
------------------------------------------------------------------------
Oxycodone............................       9143   II
------------------------------------------------------------------------

    The company plans to import the listed controlled substance to 
complete analytical testing.

    Dated: August 20, 2019.
Neil D. Doherty,
Acting Assistant Administrator.
[FR Doc. 2019-20417 Filed 9-19-19; 8:45 am]
 BILLING CODE 4410-09-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.